Funding for Parkinson’s Research

The Michael J. Fox Foundation (MJFF) is accepting pre-proposals for funding of Parkinson’s disease research, including from biotech and pharmaceutical companies. Of the more than $525 million to research programs MJFF has funded since 2000, $110 million in non-dilutive capital has been allocated to industry projects.

The Foundation supports research toward Parkinson’s target advancement, therapeutic development (symptomatic and disease-modifying), and improved biomarkers and outcome measures. The pre-proposal deadline is October 28.

Visit to learn more and download application instructions.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: